From Misfolding to Management: Molecular Targets Redefining Transthyretin Amyloid Cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative heart disease driven by protein instability. Normally a tetramer, transthyretin can dissociate into monomers that misfold, aggregate, and deposit as amyloid fibrils within…

Continue Reading From Misfolding to Management: Molecular Targets Redefining Transthyretin Amyloid Cardiomyopathy

Clearance and Crossroads: FDA OKs Papzimeos as Pfizer’s Sickle Cell Bet Falters

Biopharma.com reported sharp contrasts, with a landmark approval for a rare disease therapy alongside a high-profile trial miss, and a series of corporate moves reflecting market access and financing realities.…

Continue Reading Clearance and Crossroads: FDA OKs Papzimeos as Pfizer’s Sickle Cell Bet Falters